Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron, its experimental oral GLP-1 medicine to treat obesity, focusing its efforts on another medicine with a different mechanism of action
Plateaus can occur when your body adapts to a given dose, which is why dose escalation is built into most treatment protocols
Since the availability of Mounjaro (Tirzepatide) may vary over time depending on regulatory approvals, authorised supply, and distribution, patients should always confirm the latest status with a qualified doctor rather than relying on online sellers or unofficial sources
Mood takes a nosedive (think hangry but on hard mode)
Our metabolic health program assures responsive care and expertise from certified providers in Tyler, Texas, making tirzepatide treatment easy and approachable
For protein-focused options, see our guide on protein shakes for GLP-1 users